Healthcare systems have been through a lot in five years. A global pandemic. A reckoning on racial health justice. An ongoing overdose epidemic. It’s been absolutely vital not only for new, innovative approaches and programming from health systems, but also for...
A series of new drugs that show progress in slowing down early-stage Alzheimer’s symptoms have emerged on the market. One such drug, Lecanemab — approved by the FDA in 2023 — is an infusion therapy that targets amyloid plaques in the brain, which are one of the...
This is the second installment of a two-part audio series about sleep in medical residency. In the first installment, experts discussed the question: Why is quality sleep so tricky for medical residents to achieve and what are the serious ramifications of this...
Sleep is an elusive necessity for many, but especially for resident physicians who frequently work erratic schedules, as they learn to develop and hone their clinical acumen. According to a 2020 study in JAMA Network Open, lack of sleep among medical residents leads...